Latest Commercialization News

Adherium Limited has reached a pivotal commercial milestone by expanding its Remote Patient Monitoring program across 110 U.S. Allergy Partners clinics, activating nearly 70% of the network and onboarding close to 700 patients in six months.

Anatara Lifesciences has completed the final tranche of its placement, issuing over 66 million shares and granting options to its lead manager, marking a key step in its capital raising strategy.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.

PainChek Ltd has secured FDA De Novo clearance for its Adult App, marking a pivotal entry into the US long-term care market and setting the stage for global expansion including its Infant App.

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.

Eclipse Metals has engaged BGR Group, a leading U.S. government relations firm, to strengthen its strategic positioning and funding prospects for its Greenland rare earth projects, advancing its role in Western critical minerals supply chains.

Patrys Limited has expanded its clinical pipeline by acquiring Reliis Pty Ltd, gaining a proprietary injectable formulation of Quetiapine aimed at the large and underserved delirium market. This strategic move balances Patrys’ portfolio with a near-term pharmaceutical asset alongside its biologics program.

Syntara Limited has successfully completed Phase 1a trials for its topical anti-fibrotic drug SNT-9465, demonstrating dose-dependent target engagement and safety, and is now progressing to an innovative Phase 1b study in hypertrophic scars.

88 Energy Limited updates on its Alaska-based Project Phoenix, announcing a fully funded horizontal well and extended flow test scheduled for Q3 2026, backed by joint venture partner Burgundy Xploration LLC. The project is positioned for first production as early as 2027 amid a resurgence in North Slope activity.

Delorean Corporation has teamed up with Paper Australia (Opal) to explore a renewable energy project at the Maryvale Paper Mill, aiming to convert organic waste into green gas and electricity through anaerobic digestion.

Synertec has secured a pivotal contract to supply its zero-emission Powerhouse system to Shell QGC’s Coal Seam Gas operations in Queensland, marking a significant step in industrial decarbonisation.

Electro Optic Systems has completed its acquisition of the UK-based Interceptor business, marking a strategic expansion into the AUKUS market and enhancing its counter-drone technology portfolio.